ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Owkin
Owkin is an AI company focused on biological research and drug discovery, developing large language models and multimodal data analysis tools for scientists and clinicians.
Headquarters
New York, New York, United States
Company Size
201-500 employees
Founded
2016
Owkin is an AI biotech company that applies agentic reasoning and advanced machine learning to understand complex biology and accelerate biomedical research. Its platform — including the K Pro agentic decision-making tool for biopharma — combines privacy-preserving, federated-style approaches and predictive modeling to help discover biomarkers, optimize clinical trials, and support drug development. Owkin partners with hospitals, pharma companies, and research institutions and publishes scientific work while emphasizing AI ethics and responsible deployment. Their stated mission is to transform research toward a “biological artificial superintelligence” that improves patient outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Owkin.
Owkin didn’t post a salary, so this is our estimate from similar listings.
Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing
8 hours ago
